← Eichor
Condition: Childhood Lymphoblastic Lymphoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Childhood Lymphoblastic Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considerin
NA · 1 location(s) · Columbia University · NCT05963971Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT06747910Newly-diagnosed Pediatric T-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06855810Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
Phase N/A · 4 location(s) · University of Aarhus · NCT06367725Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06764238Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL
Phase 1 · 3 location(s) · Chulalongkorn University · NCT07078929Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Agai
NA · 1 location(s) · Murdoch Childrens Research Institute · NCT07325305Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA · 3 location(s) · University Hospital, Tours · NCT05792007CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
Phase 1 · 1 location(s) · National University Hospital, Singapore · NCT05043571A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymp
Phase N/A · 2 location(s) · University Children's Hospital Basel · NCT06861530The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
NA · 1 location(s) · Ege University · NCT07203742CAR-T Cell Therapy for ALL
EARLY_Phase 1 · 1 location(s) · Dr. Zaineb Akram · NCT07695012International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Phase 2 · 15 location(s) · Charite University, Berlin, Germany · NCT03590171Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Pat
Phase N/A · 1 location(s) · Mayo Clinic · NCT07071051A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants
Phase N/A · 2 location(s) · Arkansas Children's Hospital Research Institute · NCT07422337Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06882057Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · 115 location(s) · Martin Schrappe · NCT03643276Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
Phase N/A · 4 location(s) · IRCCS Burlo Garofolo · NCT05811845Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Phase 1/Phase 2 · 11 location(s) · University Hospital Tuebingen · NCT05366218Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06575296Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · 228 location(s) · University Hospital Muenster · NCT04043494A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With Firs
Phase 2 · 68 location(s) · Pfizer · NCT05748171Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
Phase N/A · 3 location(s) · French Africa Pediatric Oncology Group · NCT04794296Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Phase 1 · 2 location(s) · University of Chicago · NCT03571321A Registry for People With T-cell Lymphoma
Phase N/A · 26 location(s) · Memorial Sloan Kettering Cancer Center · NCT05978141More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes Aft
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT07705178InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Phase N/A · 8 location(s) · Columbia University · NCT05929976CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT06326463
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.